Immune thrombocytopenic purpura cases following COVID-19 vaccination.

Main Article Content

Annalisa Condorelli
a:1:{s:5:"en_US";s:107:"1Division of Hematology, AOU "Policlinico G. Rodolico-San Marco", Via Santa Sofia 78, 95124 Catania, Italy.";}

Uros Markovic
Roberta Sciortino
Mary Ann Di Giorgio
Daniela Nicolosi
Gaetano Giuffrida

Keywords

COVID 19, Immune thrombocytopenic purpura, Adverse event, Vaccination

Abstract

Not requested.

Downloads

Download data is not yet available.


Abstract 816
PDF Downloads 296
HTML Downloads 188

References

1. Rodeghiero F. Practical recommendations for the management of patients with ITP during the COVID-19 Pandemic. Mediterr J Hematol Infect Dis. 2021;13(1). doi:10.4084/mjhid.2021.032
2. Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603-2615. doi:10.1056/nejmoa2034577
3. Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99-111. doi:10.1016/S0140-6736(20)32661-1
4. Perricone C, Ceccarelli F, Nesher G, et al. Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases. Immunol Res. 2014;60(2-3):226-235. doi:10.1007/s12026-014-8597-x
5. Helms JM, Ansteatt KT, Roberts JC, et al. Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine. J Blood Med. 2021;Volume 12:221-224. doi:10.2147/jbm.s307047
6. Malayala S V, Mohan G, Vasireddy D, Atluri P. Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine. Cureus. 2021. doi:10.7759/cureus.14099
7. Lee EJ, Cines DB, Gernsheimer T, et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 2021. doi:10.1002/ajh.26132
8. Candelli Marcello, Rossi Elena, Valletta Federico, De Stefano Valerio FF. Immune thrombocytopenic purpura after SARS-CoV-2 vaccine. Br Soc Haematol John Wiley Sons Ltd. 2021.
9. Welsh KJ, Baumblatt J, Chege W, Goud R, Nair N. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2021. doi:10.1016/j.vaccine.2021.04.054
10. Cines DB, Bussel JB. SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia. N Engl J Med. 2021. doi:10.1056/nejme2106315

Article Sidebar

PDF HTML
Published
Jun 28, 2021
DOI https://doi.org/10.4084/MJHID.2021.047

Article Details

How to Cite

Condorelli, A. (2021) “Immune thrombocytopenic purpura cases following COVID-19 vaccination. ”, Mediterranean Journal of Hematology and Infectious Diseases, 13(1), p. e2021047. doi: 10.4084/MJHID.2021.047.
Issue
Vol. 13 No. 1 (2021): Mediterranean Journal of Hematology and Infectious Diseases, Volume 13, 2021
Section
Letters to the Editor
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.